<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Candidiasis is the most common opportunistic yeast infection, with <italic>Candida albicans</italic> as a paramount causative species. (1,3)-<italic>β</italic>-D-glucan is one of the three main targets of clinically available antifungal agents used to treat <italic>Candida</italic> infections. It is one of the most abundant fungal cell wall components. Echinocandins represent the newest class of antifungals affecting cell wall biosynthesis through non-competitive inhibition of (1,3)-<italic>β</italic>-D-glucan synthase. Therefore, treatment with echinocandins causes defects in fungal cell integrity. In the present study, similar activity of emodin (6-methyl-1,3,8-trihydroxyanthraquinone) has been revealed. Many reports have already shown the antifungal potential of this pleiotropic molecule, including its activity against <italic>C. albicans</italic>. The aim of this report was to evaluate the activity of emodin towards a new molecular target, i.e. (1,3)-<italic>β</italic>-D-glucan synthase isolated from <italic>Candida</italic> cells. Moreover, given the identical mechanism of the activity of both molecules, interaction of emodin with caspofungin was determined. The study revealed that emodin reduced (1,3)-<italic>β</italic>-D-glucan synthase activity and increased cell wall damage, which was evidenced by both a sorbitol protection assay and an aniline blue staining assay. Furthermore, the synergy testing method showed mainly independence of the action of both tested antifungal agents, i.e. emodin and caspofungin used in combination.</p></abstract>

Candidiasis is the most common opportunistic yeast infection, with Candida albicans as a paramount causative species. (1,3)-β-D-glucan is one of the three main targets of clinically available antifungal agents used to treat Candida infections. It is one of the most abundant fungal cell wall components. Echinocandins represent the newest class of antifungals affecting cell wall biosynthesis through non-competitive inhibition of (1,3)-β-D-glucan synthase. Therefore, treatment with echinocandins causes defects in fungal cell integrity. In the present study, similar activity of emodin (6-methyl-1,3,8-trihydroxyanthraquinone) has been revealed. Many reports have already shown the antifungal potential of this pleiotropic molecule, including its activity against C. albicans. The aim of this report was to evaluate the activity of emodin towards a new molecular target, i.e. (1,3)-β-D-glucan synthase isolated from Candida cells. Moreover, given the identical mechanism of the activity of both molecules, interaction of emodin with caspofungin was determined. The study revealed that emodin reduced (1,3)-β-D-glucan synthase activity and increased cell wall damage, which was evidenced by both a sorbitol protection assay and an aniline blue staining assay. Furthermore, the synergy testing method showed mainly independence of the action of both tested antifungal agents, i.e. emodin and caspofungin used in combination.

Emodin Reduces the Activity of (1,3)-<italic>β</italic>-D-glucan Synthase from <italic>Candida albicans</italic> and Does Not Interact with Caspofungin

Polish Journal of Microbiology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Emodin Reduces the Activity of (1,3)--D-glucan Synthase from  and Does Not Interact with Caspofungin

Candidiasis is the most common opportunistic yeast infection, with Candida albicans as a paramount causative species. (1,3)-β-D-glucan is one of the three main...

Emodin Reduces the Activity of (1,3)-β-D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin

Article Category: original-paper

Pubblicato online: 10 dic 2018

Pagine: 463 - 470

Ricevuto: 20 giu 2018

Accettato: 04 set 2018

DOI: https://doi.org/10.21307/pjm-2018-054

Parole chiave
caspofungin, echinocandins, emodin, (1,3)--D-glucan synthase

© 2018 Monika Janeczko published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Emodin Reduces the Activity of (1,3)-β-D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin

Article Category: original-paper

Pubblicato online: 10 dic 2018

Pagine: 463 - 470

Ricevuto: 20 giu 2018

Accettato: 04 set 2018

DOI: https://doi.org/10.21307/pjm-2018-054

Parole chiavecaspofungin, echinocandins, emodin, (1,3)--D-glucan synthase

© 2018 Monika Janeczko published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Parole chiave
caspofungin, echinocandins, emodin, (1,3)--D-glucan synthase